The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort
Authors
Keywords
-
Journal
UPSALA JOURNAL OF MEDICAL SCIENCES
Volume 123, Issue 1, Pages 50-56
Publisher
Informa UK Limited
Online
2018-03-14
DOI
10.1080/03009734.2018.1441928
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis C: global epidemiology and strategies for control
- (2016) S. Lanini et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
- (2016) Christoph Sarrazin et al. GASTROENTEROLOGY
- Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
- (2016) Jean-Michel Pawlotsky GASTROENTEROLOGY
- The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
- (2016) Christoph Sarrazin JOURNAL OF HEPATOLOGY
- Literature review of the distribution of hepatitis C virus genotypes across Europe
- (2016) Alfredo Alberti et al. JOURNAL OF MEDICAL VIROLOGY
- An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
- (2016) Tarik Asselah et al. PLoS One
- Hepatitis C virus drug resistance-associated substitutions: State of the art summary
- (2015) Erik Lontok et al. HEPATOLOGY
- Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort
- (2015) Samantha J. Shepherd et al. JOURNAL OF CLINICAL VIROLOGY
- Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET
- (2015) Stuart C. Gordon et al. JOURNAL OF HEPATOLOGY
- Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy
- (2015) Christoph Sarrazin et al. JOURNAL OF VIROLOGICAL METHODS
- Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study
- (2015) Frédégonde About et al. PLoS One
- Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis
- (2015) Antonia Lepida et al. PLoS One
- IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders
- (2015) Giorgio Calisti et al. SpringerPlus
- Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
- (2014) V. Saxena et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Update on hepatitis C virus resistance to direct-acting antiviral agents
- (2014) Eva Poveda et al. ANTIVIRAL RESEARCH
- Antiviral therapy of hepatitis C in 2014: Do we need resistance testing?
- (2014) Maximilian David Schneider et al. ANTIVIRAL RESEARCH
- Low SVR Rates in Clinical Practice for Treating Genotype 1 Chronic Hepatitis C with Protease Inhibitors Boceprevir and Telaprevir
- (2014) Perry H. Dubin et al. DIGESTIVE DISEASES AND SCIENCES
- Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
- (2014) Christophe Hézode et al. GASTROENTEROLOGY
- Importance of HCV genotype 1 subtypes for drug resistance and response to therapy
- (2014) D. L. Wyles et al. JOURNAL OF VIRAL HEPATITIS
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- (2014) Eric Lawitz et al. LANCET
- The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies
- (2014) Ann-Sofi Duberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a
- (2013) Navaneethan Palanisamy et al. ANTIVIRAL RESEARCH
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review
- (2013) Shuang Wu WORLD JOURNAL OF GASTROENTEROLOGY
- The role of resistance in HCV treatment
- (2012) Johannes Vermehren et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care
- (2012) Brian L Pearlman LANCET INFECTIOUS DISEASES
- Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations
- (2012) Martin Lagging et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- IL28B single nucleotide polymorphisms in the treatment of hepatitis C
- (2011) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors
- (2010) A. Bae et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started